Alan Jacobs
Keine laufenden Positionen mehr
Vermögen: - $ am 31.05.2024
Profil
Alan K.
Jacobs worked as a Vice President of Clinical Development at Boston Pharmaceuticals, Inc. He also worked as a Chief Medical Officer at Satellos Bioscience, Inc. from 2023 to 2024.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SATELLOS BIOSCIENCE INC
-.--% | 07.06.2023 | 0 ( -.--% ) | - $ | 31.05.2024 |
Ehemalige bekannte Positionen von Alan Jacobs
Unternehmen | Position | Ende |
---|---|---|
SATELLOS BIOSCIENCE INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.01.2024 |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SATELLOS BIOSCIENCE INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |